• Text size
  • Send this article to a friend
  • Print this article

Glaxo rises as US drug

Shares in GlaxoSmithKline rose and the drugmaker confirmed its 2007 earnings outlook yesterday after a US Food and Drug Administration panel recommended that its diabetes drug Avandia remain on the market, but with stronger health warnings.

Custom byline text: 
heraldscotland staff

JANE WARDELL

Shares in GlaxoSmithKline rose and the drugmaker confirmed its 2007 earnings outlook yesterday after a US Food and Drug Administration panel recommended that its diabetes drug Avandia remain on the market, but with stronger health warnings.